Plan A highlighted in article on male birth control

The promise of new male contraceptive options was highlighted in an article by Kelcie Moseley-Morris published in News from the States. Heather Vahdat of the Male Contraceptive Initiative, which supports much of the research on new male contraceptives, mentioned that demand for male contraceptives was already stronger than most would guess. Research showed that across the world, 78% of men surveyed said they would use male contraceptive methods if available. In the U.S. the need for contraceptive options for men became urgent with the Supreme Court’s Dobbs decision in 2022.

“Since the overturn of Roe, the only effective contraceptive option for men is currently a vasectomy, which solves the long-lasting problem, but is designed to be permanent,” noted L.R. Fox, the CEO of NEXT Life Sciences, which is developing Plan A to be a nonhormonal, long-lasting, and reversible male birth control using Vasalgel technology. Vasectomy is usually considered to be permanent, and is most often used by men who are done having children. Fox said there’s a massive demand for reversible birth control from younger men who wish to take part in the family planning process.

For more information, check out the Male Contraceptive Initiative and consider supporting their work.

You can learn more about Plan A and NEXT Life Sciences by visiting their website — and sign up here to receive updates on progress.

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today